Trials / Unknown
UnknownNCT05580198
Prognostic Markers of Post-Stroke Depression (PROMoSD)
Prognostic Markers of Post-Stroke Depression: A Single-center Prospective Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (estimated)
- Sponsor
- Ruhr University of Bochum · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Single-center prospective observational study investigating the association of brainstem raphe hypoechogenicity detected by transcranial sonography and post-stroke depression three months after an acute ischemic stroke.
Detailed description
Post-stroke depression (PSD) is an important complication after a stroke. Despite significant limitations between studies of PSD risk factors, stroke severity or post-stroke disability, prior depressive episodes, and female sex are arguably the most well-known risk factors for developing PSD, although the predictive value of these factors is limited. A hypoechogenic brainstem raphe (BR) detected by transcranial sonography (TCS) is associated with depressive symptoms in distinct diseases but is also common with approximately 25% of the non-depressed population in Europe. The primary aim of this study is to investigate the association between BR hypoechogenicity and PSD occurrence in a prospective observational study design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Transcranial sonography. | Transcranial sonography examination to determine the brainstem raphe echogenicity. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-11-01
- Completion
- 2023-03-01
- First posted
- 2022-10-14
- Last updated
- 2022-10-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05580198. Inclusion in this directory is not an endorsement.